Difference between revisions of "Event:119"
From AOP-Wiki
(Migrating page to new template) |
|||
Line 2: | Line 2: | ||
__ForceTOC__ | __ForceTOC__ | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | + | == Event Title == | |
− | + | <div id='longTitle' class='Title'>Gap, N/A</div> | |
− | + | <div id='shortTitle' class='Title2'>Short name: Gap, N/A</div> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | < | + | |
− | + | ||
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | </ | + | |
== Key Event Overview == | == Key Event Overview == | ||
Line 61: | Line 35: | ||
=== Taxonomic Applicability === | === Taxonomic Applicability === | ||
− | + | ||
− | + | ||
− | + | ||
<div id="popbox6" title='Add a Record' style='display:none'> | <div id="popbox6" title='Add a Record' style='display:none'> | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
Line 111: | Line 58: | ||
=== Level of Biological Organization === | === Level of Biological Organization === | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
{|class="wikitable sortable" id="BioProof" | {|class="wikitable sortable" id="BioProof" |
Revision as of 18:23, 28 September 2014
Contents
Event Title
Gap, N/A
Short name: Gap, N/A
Key Event Overview
AOPs Including This Key Event
AOP Name | Molecular Initiating Event? | Essentiality |
---|---|---|
Cyclooxygenase inhibition leading reproductive failure | No |
Taxonomic Applicability
Common Name | Scientific Name | Evidence | Links |
---|
Level of Biological Organization
Biological Organization |
---|
How this Key Event works
How it is Measured or Detected
Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?